C-Carbs Program for Diabetes

(C-Carbs Trial)

This trial tests whether an educational program, the C-Carbs Program, can help people with diabetes improve insulin use at mealtimes by using a continuous glucose monitor (CGM). Participants will be divided into two groups: one will follow the new program, while the other will continue with their usual care. This study targets adults who have had diabetes for at least a year, use daily insulin shots, and do not typically count carbohydrates when dosing insulin. Participants must be willing to use a CGM and attend study sessions. The goal is to determine if this approach can enhance insulin use and blood sugar control. As an unphased trial, this study provides a unique opportunity to explore innovative diabetes management strategies and contribute to advancing care for others.

Research has shown that diabetes self-management education programs, such as the C-Carbs Program, are generally safe. Studies indicate that these educational methods help people with diabetes manage their blood sugar levels more effectively without serious side effects. For instance, one study found that participants who received detailed education improved their blood sugar control over time. These programs teach skills that can help prevent or delay diabetes-related issues, such as heart disease or kidney problems, without causing harm. Therefore, the C-Carbs Program, which focuses on teaching about insulin dosing, is likely well-tolerated based on similar programs.¹²³⁴⁵

Researchers are excited about the C-Carbs Program for diabetes because it shifts the focus from traditional medication management to personalized lifestyle education. Unlike standard treatments like insulin therapy or oral hypoglycemics, this program involves direct interaction with a diabetes educator to tailor carbohydrate management specifically to individual needs. This hands-on, educational approach aims to empower individuals with diabetes to better understand and control their condition, potentially leading to more sustainable and effective management of their blood sugar levels.

Research has shown that technology-assisted insulin dosing can improve blood sugar control in people with diabetes. For example, one study found that 55% of participants using a tech-based program reduced their HbA1c levels to below 6.5%. HbA1c measures average blood sugar levels over several months. Another study found that low-carb diets, which can aid in insulin management, led to slight improvements in blood sugar. In this trial, participants in the intervention arm will complete the C-Carbs program, which uses continuous glucose monitoring (CGM) to guide insulin dosing, potentially enhancing diabetes management.⁶⁷⁸⁹¹⁰